Cyclin-dependent kinase 5, Munc18a and Munc18-interacting protein 1/X11α protein up-regulation in Alzheimer’s disease

Ahlijanian, 2000, Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5, Proc Natl Acad Sci U S A, 97, 2910, 10.1073/pnas.040577797 Alvarez, 2001, A cdk5-p35 stable complex is involved in the β-amyloid-induced deregulation of cdk5 activity in hippocampal neurons, Exp Cell Res, 264, 266, 10.1006/excr.2001.5152 1987 Beach, 1992, Cholinergic fiber loss occurs in the absence of synaptophysin depletion in Alzheimer’s disease primary visual cortex, Neurosci Lett, 142, 253, 10.1016/0304-3940(92)90385-K Biederer, 2000, Mints as adaptors. Direct binding to neurexins and recruitment of Munc18, J Biol Chem, 275, 39803, 10.1074/jbc.C000656200 Biederer, 2002, Regulation of APP-dependent transcription complexes by Mint/X11s, J Neurosci, 22, 7340, 10.1523/JNEUROSCI.22-17-07340.2002 Borg, 1998, The X11alpha protein slows cellular amyloid precursor protein processing and reduces Abeta40 and Abeta42 secretion, J Biol Chem, 273, 14761, 10.1074/jbc.273.24.14761 Braak, 1991, Neuropathological staging of Alzheimer-related changes, Acta Neuropathol, 82, 239, 10.1007/BF00308809 Braak, 1998, Evolution of Alzheimer’s disease related cortical lesions, J Neural Transm Suppl, 54, 97, 10.1007/978-3-7091-7508-8_9 Bradford, 1976, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal Biochem, 72, 248, 10.1016/0003-2697(76)90527-3 Brun, 1983, An overview of light and electron microscopic changes, 37 Cruz, 2003, Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles, Neuron, 40, 471, 10.1016/S0896-6273(03)00627-5 DeKosky, 2002, Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment, Ann Neurol, 51, 145, 10.1002/ana.10069 Delacourte, 1999, The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer’s disease, Neurology, 52, 1158, 10.1212/WNL.52.6.1158 Dhavan, 2001, A decade of CDK5, Nat Rev Mol Cell Biol, 2, 749, 10.1038/35096019 Fletcher, 1999, Regulation of exocytosis by cyclin-dependent kinase 5 via phosphorylation of Munc18, J Biol Chem, 274, 4027, 10.1074/jbc.274.7.4027 Folstein, 1975, “Mini-Mental State”: A practical method for grading the cognitive state of patients for the clinician, J Psychiat Res, 12, 189, 10.1016/0022-3956(75)90026-6 Francis, 1993, Cortical pyramidal neurone loss may cause glutamatergic hypoactivity and cognitive impairment in Alzheimer’s disease, J Neurochem, 60, 1589, 10.1111/j.1471-4159.1993.tb13381.x Francis, 1999, The cholinergic hypothesis of Alzheimer’s disease, J Neurol Neurosurg Psychiatry, 66, 137, 10.1136/jnnp.66.2.137 Gallwitz, 2003, The riddle of the Sec1/Munc-18 proteins, Trends Biochem Sci, 28, 113, 10.1016/S0968-0004(03)00028-8 Hardy, 1985, The patients dying after long terminal phase have acidotic brains, J Neural Transm, 61, 253, 10.1007/BF01251916 Haug, 1996, Decreased inositol (1,4,5)-triphosphate receptor levels in Alzheimer’s disease cerebral cortex, Neurodegeneration, 5, 169, 10.1006/neur.1996.0024 Hill, 2003, Munc18 interacting proteins, J Biol Chem, 278, 36032, 10.1074/jbc.M301632200 Ho, 2003, A role for Mints in transmitter release, Proc Natl Acad Sci U S A, 100, 1409, 10.1073/pnas.252774899 Ho, 2002, Synergistic effects of Munc18a and X11 proteins on amyloid precursor protein metabolism, J Biol Chem, 30, 27021, 10.1074/jbc.M201823200 Hofman, 1991, The prevalence of dementia in Europe, Int J Epidemiol, 20, 736, 10.1093/ije/20.3.736 Honer, 1992, Regional synaptic pathology in Alzheimer’s disease, Neurobiol Aging, 13, 375, 10.1016/0197-4580(92)90111-A Hope, 1992, The Present Behavioural Examination (PBE), Psychol Med, 22, 223, 10.1017/S0033291700032888 Hope, 1997, Behaviour changes in dementia. I. Point of entry data of a prospective study, Int J Geriatr Psychiatry, 12, 1062, 10.1002/(SICI)1099-1166(199711)12:11<1062::AID-GPS675>3.0.CO;2-N Hope, 1997, Behaviour changes in dementia. II. Are there behavioural syndromes?, Int J Geriatr Psychiatry, 12, 1074, 10.1002/(SICI)1099-1166(199711)12:11<1074::AID-GPS696>3.0.CO;2-B Hope, 1999, Natural history of behavioural changes and psychiatric symptoms in Alzheimer’s disease, Br J Psychiatry, 174, 39, 10.1192/bjp.174.1.39 Hsiao, 1996, Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice, Science, 274, 99, 10.1126/science.274.5284.99 Ikonomovic, 2003, Cholinergic plasticity in hippocampus of individuals with mild cognitive impairment, J Alzheimers Dis, 5, 39, 10.3233/JAD-2003-5106 Irizarry, 1997, APPSw transgenic mice develop age-related Aβ deposits and neuropil abnormalities, but no neuronal loss in CA1, J Neuropathol Exp Neurol, 56, 965, 10.1097/00005072-199709000-00002 King, 2002, Maintained synaptophysin immunoreactivity in Tg2576 transgenic mice during aging, Brain Res, 926, 58, 10.1016/S0006-8993(01)03294-2 King, 2003, X11α modulates secretory and endocytotic trafficking and metabolism of amyloid precursor protein, Neuroscience, 120, 143, 10.1016/S0306-4522(03)00284-7 King, 2004, X11α impairs γ- but not β-cleavage of amyloid precursor protein, J Neurochem, 88, 971, 10.1046/j.1471-4159.2003.02234.x Lee, 2003, The neuronal adaptor protein X11α reduces Aβ levels in the brains of Alzheimer’s APPswe Tg2576 transgenic mice, J Biol Chem, 278, 47025, 10.1074/jbc.M300503200 Lee, 2004, The neuronal adaptor protein X11β reduces amyloid β-protein levels and amyloid plaque formation in the brains of transgenic mice, J Biol Chem, 279, 49099, 10.1074/jbc.M405602200 Lee, 2000, Neurotoxicity induces cleavage of p35 to p25 by calpain, Nature, 405, 360, 10.1038/35012636 Masliah, 1989, Immunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer disease, Neurosci Lett, 103, 234, 10.1016/0304-3940(89)90582-X Masliah, 1991, Cortical and subcortical patterns of synaptophysinlike immunoreactivity in Alzheimer’s disease, Am J Pathol, 138, 235 McKhann, 1984, Clinical diagnosis of Alzheimer’s disease, Neurology, 34, 939, 10.1212/WNL.34.7.939 McLoughlin, 1999, Mint2/X11-like colocalizes with the Alzheimer’s disease amyloid precursor protein and is associated with neuritic plaques in Alzheimer’s disease, Eur J Neurosci, 11, 1988, 10.1046/j.1460-9568.1999.00610.x Mirra, 1991, The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer’s disease, Neurology, 41, 479, 10.1212/WNL.41.4.479 Mori, 2002, Alteration of methamphetamine-induced striatal dopamine release in mint-1 knockout mice, Neurosci Res, 43, 251, 10.1016/S0168-0102(02)00041-X Mueller, 2000, Modulation of amyloid precursor protein metabolism by X11α/Mint-1, J Biol Chem, 275, 39302, 10.1074/jbc.M008453200 Nishimura, 2000, Changes in Mint1, a novel synaptic protein, after transient global ischemia in mouse hippocampus, J Cereb Blood Flow Metab, 20, 1437, 10.1097/00004647-200010000-00005 Noble, 2003, Cdk5 is a key factor in tau aggregation and tangle formation in vivo, Neuron, 38, 555, 10.1016/S0896-6273(03)00259-9 Okamoto, 1997, Mints, Munc18-interacting proteins in synaptic vesicle exocytosis, J Biol Chem, 272, 31459, 10.1074/jbc.272.50.31459 Okamoto, 1998, Mint3, Eur J Cell Biol, 77, 161, 10.1016/S0171-9335(98)80103-9 Palmer, 1987, Monoaminergic innervation of the frontal and temporal lobes in Alzheimer’s disease, Brain Res, 401, 231, 10.1016/0006-8993(87)91408-9 Patrick, 1998, P35, the neuronal-specific activator of cyclin-dependent kinase 5 (cdk5) is degraded by the ubiquitin-proteasome pathway, J Biol Chem, 273, 24057, 10.1074/jbc.273.37.24057 Patrick, 1999, Conversion of p35 to p25 deregulates cdk5 activity and promotes neurodegeneration, Nature, 402, 615, 10.1038/45159 Pérez-Brangulí, 2002, Munc 18a binding to syntaxin 1A and 1B isoforms defines its localization at the plasma membrane and blocks SNARE assembly in a three-hybrid system assay, Mol Cell Neurosci, 20, 169, 10.1006/mcne.2002.1122 Rizo, 2002, SNAREs and Munc18 in synaptic vesicle fusion, Nat Rev Neurosci, 3, 641, 10.1038/nrn898 Roth, 1986, CAMDEX, Br J Psychiatry, 149, 698, 10.1192/bjp.149.6.698 Ruiz-Montasell, 1996, Differential distribution of syntaxin isoforms 1A and 1B in the rat central nervous system, Eur J Neurosci, 8, 2544, 10.1111/j.1460-9568.1996.tb01548.x Sastre, 1998, The X11α protein slows cellular amyloid precursor protein processing and reduces Aβ40 and Aβ42 secretion, J Biol Chem, 273, 22351, 10.1074/jbc.273.35.22351 Savage, 2002, Activation of c-Jun N-terminal kinase and p38 in an Alzheimer’s disease model is associated with amyloid deposition, J Neurosci, 22, 3376, 10.1523/JNEUROSCI.22-09-03376.2002 Scorza, 2003, Levels of the synaptic protein X11alpha/mint1 are increased in hippocampus of rats with epilepsy, Epilepsy Res, 57, 49, 10.1016/j.eplepsyres.2003.10.010 Shuang, 1998, Regulation of Munc-18/syntaxin 1A interaction by cyclin-dependent kinase 5 in nerve endings, J Biol Chem, 273, 4957, 10.1074/jbc.273.9.4957 Smith, 2002, Cdk5 behind the wheel, Trends Cell Biol, 12, 28, 10.1016/S0962-8924(01)02181-X Sze, 1997, Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease, J Neuropathol Exp Neurol, 56, 933, 10.1097/00005072-199708000-00011 Takashima, 2001, Involvement of cyclin dependent kinase 5 activator p25 on tau phosphorylation in mouse brain, Neurosci Lett, 306, 37, 10.1016/S0304-3940(01)01864-X Takeuchi, 2001, Age-related amyloid β deposition in transgenic mice overexpressing both Alzheimer mutant presenilin 1 and amyloid β precursor protein Swedish mutant is not associated with global neuronal loss, Am J Pathol, 157, 331, 10.1016/S0002-9440(10)64544-0 Tandon, 2003, Brain levels of CDK5 activator p25 are not increased in Alzheimer’s or other neurodegenerative diseases with neurofibrillary tangles, J Neurochem, 86, 572, 10.1046/j.1471-4159.2003.01865.x Taniguchi, 2001, Calpain-mediated degradation of p35 to p25 in postmortem human and rat brains, FEBS Lett, 489, 46, 10.1016/S0014-5793(00)02431-5 Taru, 2004, Facilitation of stress-induced phosphorylation of β-amyloid precursor protein family members by X11-like/Mint2 protein, J Biol Chem, 279, 21628, 10.1074/jbc.M312007200 Tomita, 1999, Interaction of a neuron-specific protein containing PDZ domains with Alzheimer’s amyloid precursor protein, J Biol Chem, 274, 2243, 10.1074/jbc.274.4.2243 Tseng, 2002, A survey of Cdk5 activator p35 and p25 levels in Alzheimer’s disease brains, FEBS Lett, 523, 58, 10.1016/S0014-5793(02)02934-4 Valtorta, 1989, Synaptophysin and synapsin I as tools for the study of the exo-endocytotic cycle, Cell Biol Int Rep, 13, 1023, 10.1016/0309-1651(89)90017-9 Yoo, 2001, p25 Protein in neuodegeneration, Nature, 411, 763, 10.1038/35081146